home > News and Publications > Publications
 

  • Governor Pritzker Must Act on Outrageous Prejudgment Interest Bill by First Week of April!

    The prejudgment interest bill is still on the governor’s desk but must be acted on soon! 

    House Bill 3360 would radically increase medical liability lawsuit payments through the collection of prejudgment interest – at a rate of 9% per year.

    CONTINUE to contact Governor Pritzker and urge his VETO of House Bill 3360.

    Your action is critical!

    Click here to contact Governor Pritzker.

    If you have questions, please contact ISMS Senior Vice President of Legislative Affairs Erin O'Brien by email



  • Contact Your State Representative Today to Support House Bill 711 and Reform Prior Authorization

    Legislation that will address bureaucratic delays caused by prior authorization is advancing further in Springfield. On Tuesday, ISMS-backed legislation ( House Bill 711) was voted favorably out of the House Human Services Committee

    Known as the Prior Authorization Reform Act, some of the key provisions of this comprehensive initiative include:

    • Establishing deadlines for prior authorization decisions – 24 hours for urgent care services and 72 hours for nonurgent care – so patients would no longer have to worry about insurers’ decision-making delays causing further damage to their health. 
    • Ensuring that prior authorization requirements are based on medical evidence and that decisions are administered by qualified professionals.

    Your help is needed! Please contact your state representative today and urge support of House Bill 711 – The Prior Authorization Reform Act.

    Learn more at www.YourCareCantWait.org.

    If you have questions, please contact ISMS Senior Vice President of Legislative Affairs Erin O'Brien by email



  • ISMS Offers Resource Explaining New Federal Rule on 'Information Blocking'

    A new federal rule that takes effect on April 5 impacts individual physicians and physician groups who use electronic health records (EHRs). The rule pertains to “information blocking,” a term that describes obstructing access to information in an individual’s electronic health record. 

    Broadly speaking, the rule requires physicians to make patients’ electronic health information available on request without imposing restrictions, excessive delays or other deliberate interference.

    ISMS has assembled an Issue Brief of frequently asked questions based on our members’ questions related to the new federal rule on information blocking and the release of electronic health information.

    If you need assistance, please contact the ISMS Health Policy Research and Advocacy team by email.



  • Meet Your 2021 Candidates for Office!

    On April 24, the slate of 2021-22 trustees and officers will be voted on during the ISMS Annual Meeting, taking place virtually this year. Regan Thomas, MD, was previously elected as our president-elect and will assume the office of president on that date. 

    We extend special gratitude to outgoing ISMS President Robert W. Panton, MD, for his excellent representation of ISMS over the course of the last year, including serving his entire term during the COVID-19 pandemic. 

    Be sure to register for the Annual Meeting to participate in the election and resolution review process.

    If you have questions, please send us an email



  • Register Now for These Live Webinars – at No Cost!

    What Physicians and Their Patients Need to Know About COVID-19 Vaccine Development, Safety and Administration

    March 15 | Noon to 1 p.m.

    As the global SARS-CoV-2 pandemic has now reached its one-year anniversary, an unprecedented effort to develop, distribute and administer vaccines to combat the virus is underway. The FDA’s approval for emergency use of multiple COVID-19 vaccines is a great success, but approval is just the beginning of the mass vaccination effort. This webinar will feature experts discussing approved vaccines, vaccine safety and the physician’s role in the COVID-19 vaccination effort.

    • ISMS members and their staff can participate at no cost.
    • CME offered | Register here

    Medication Safety Considerations During the COVID-19 Pandemic

    March 16 | Noon to 1 p.m.

    In the midst of the pandemic, information related to medications used for COVID-19 treatment is rapidly changing. This could pose significant risks, including adverse drug interactions and polypharmacy, for physicians and patients when adding COVID-19 treatments to a patient’s medication regimen.

    Minimizing this risk is of utmost importance in providing safe patient care.

    Join ISMIE Mutual’s* webinar to address this risk, covering risk management strategies for COVID-19 treatments and supportive/alternative therapies, along with the latest guidance and common adverse effects.

    • ISMS members, ISMIE policyholders and their staffs can participate at no cost.
    • CME offered | Register here.

      *As ISMS’ endorsed carrier, ISMIE has allowed special access to this activity to ISMS members.




View Full Site View Mobile Site